Magnesium compositions and uses thereof for metabolic disorders
A composition for administration to a subject, such as oral administration to a subject, for example, has been provided. Such a composition may comprise at least one magnesium-counter ion compound. A magnesium-counter ion composition described herein may be useful for any of a variety of applications provided herein, such as maintaining, enhancing, and/or improving health, nutrition, and/or another condition of a subject, and/or cognitive, learning, and/or memory function. A magnesium-counter ion composition provided herein may be useful for administration to a subject presenting magnesium deficiency, mild cognitive impairment, Alzheimer's disease, attention deficit hyperactivity disorder, ALS, Parkinson's disease, diabetes, migraine, anxiety disorder, mood disorder, and/or hypertension. A kit, method, and other associated technology are also provided.
1. A method of increasing magnesium in a subject comprising administering to said subject for a period of at least about 1 month a composition formulated for oral consumption, said composition comprising at least 10 mg magnesium threonate.
2. The method of claim 1 , further comprising measuring a body fluid concentration of magnesium in the subject after fasting for at least about twelve hours, wherein said body fluid concentration is serum concentration, plasma concentration, or cerebrospinal fluid concentration.
3. The method of claim 1 , wherein said magnesium threonate is provided in a magnesium-supplemented foodstuff.
4. A method of supplementing magnesium to a subject, comprising the steps of:
administering to said subject a composition comprising magnesium threonate formulated for oral consumption in an amount that is effective in increasing an initial physiological concentration of magnesium of said subject by at least about 10%, wherein the initial physiological concentration is measured from a body fluid sample taken from said subject under a fasting condition.
5. The method of claim 4 , wherein said concentration of magnesium is measured after fasting for at least about twelve hours.
6. The method of claim 4 , wherein said physiological concentration is serum concentration, plasma concentration, urine concentration, or cerebrospinal fluid concentration.
7. The method of claim 4 , wherein said magnesium threonate is provided in a magnesium-supplemented foodstuff.
8. The method of claim 4 , further comprising the step of determining a physiological concentration of magnesium after said subject has begun said dosing regimen.
9. The method of claim 1 , wherein said composition is administered for a period of greater than 6 months.
10. The method of claim 1 , wherein said composition is administered for a period of greater than 1 year.
11. The method of claim 1 , wherein the composition is in a unit dosage form.
12. The method of claim 1 , wherein the composition is a dietary supplement.
13. The method of claim 4 , wherein the composition is in a unit dosage form.
14. The method of claim 4 , wherein the composition is a dietary supplement.